The Boeing Co. (NYSE:BA): Current price $132.96
Once the Washington state legislature passes extending financial incentives for Boeing, and machinists at the company okay a long-term work contract, the firm is on track to build key parts of its newest jet, the 777X, in the Seattle area. On Tuesday, Governor Jay Inslee said that a provisional accord between Boeing and its main workers’ union has made the way for a deal, probably ending the much awaited decision in global aerospace. Inslee has now called for a special state legislative session to begin Thursday to approve a transportation package extending tax breaks for Boeing, and also improvements to state infrastructure.
Merck & Co. (NYSE:MRK): Current price $45.83
It appears that the number two domestic drug maker might be giving another look at the idea of separating its businesses after the breakup of its bigger competitor Pfizer Inc. lifted its shareholder value by $50 billion. Merck Chair and Chief Executive Ken Frazier has said that he is looking at whether the animal health division and consumer products would do better outside the company. If Merck does elect to trim its focus on human medicines, it would follow Pfizer, which spun off its animal-health business and divested its baby formula business. Another drug major, Novartis AG, identified its animal health division as a top candidate to sell off, according to a Bloomberg News report on Tuesday.
JPMorgan Chase & Co. (NYSE:JPM): Current price $51.97
Chief Executive Jamie Dimon had a mouthful for his employees at a town hall meeting at the bank’s office in the Canary Wharf of London last week, according to an attendee who wished to remain anonymous. Dimon stressed that employees be vigilant in regards to their language in e-mails and instant messages, while regulatory scrutiny of traders’ written communications ramps up, said two persons having knowledge of his comments. The CEO urged, “Don’t exaggerate, don’t ruminate, don’t [BS]. I’m serious.”